This inventor holds 2 USPTO granted patents. Top assignee: Helsinki University Licensing, Ltd.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: Pentti Kuusela: Innovator in Staphylococcus aureus Detection
Introduction
Pentti Kuusela is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medical diagnostics, particularly in the detection of Staphylococcus aureus. With a total of two patents to his name, Kuusela's work is recognized for its innovative approach to addressing critical health challenges.
Latest Patents
Kuusela's latest patents focus on methods and materials for the detection of Staphylococcus aureus, including methicillin-resistant strains. The first patent discloses a novel method for detection, highlighting an approximately 230 kDa protein that can be utilized in detection assays. This protein is also applicable in various diagnostic and therapeutic contexts. The second patent reiterates the same innovative method and emphasizes the purification of the protein and its biologically active fragments.
Career Highlights
Pentti Kuusela is affiliated with Helsinki University Licensing, Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health, particularly in combating antibiotic-resistant infections.
Collaborations
Kuusela collaborates with Pekka Hilden, contributing to the advancement of their shared research interests.
Conclusion
Pentti Kuusela's innovative work in the detection of Staphylococcus aureus showcases his commitment to improving medical diagnostics. His contributions are vital in the ongoing fight against antibiotic-resistant bacteria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile